Clear Street’s NKGen Biotech, Inc. Warrants NKGNW Stock Holding History

Clear Street’s Portfolio NKGNW Stock Details NKGNW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-491	Closed	-$40	–	864
2023 Q4	$40	Hold	491	–	–	﹤0.01%	782
2023 Q3	$194	Buy	491 +171	+53%	+$66	﹤0.01%	997
2023 Q2	$64	Hold	320	–	–	﹤0.01%	1231
2023 Q1	$45	Hold	320	–	–	﹤0.01%	1132
2022 Q4	$0	Hold	320	–	–	﹤0.01%	1190
2022 Q3	$0	Hold	320	–	–	﹤0.01%	1255
2022 Q2	$0	Buy	+320	New	+$127	﹤0.01%	1060

Other funds holding NKGNW

RCM

Rivernorth Capital Management West Palm Beach, Florida $2B AUM 0.66% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

EAM

Exos Asset Management New York $2.32K AUM 108.13% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

SCM

Shaolin Capital Management Miami, Florida $2.71B AUM 64.83% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

KIM LLC Wichita, Kansas $976M AUM 0.91% 1-Year Est. Return

TCA

Taconic Capital Advisors New York $229M AUM 110.07% 1-Year Est. Return

Clear Street's NKGNW Position: Q1 2024 in Review

Clear Street sold out of NKGen Biotech, Inc. Warrants (NKGNW) in Q1 2024, closing a stake of 491 shares — an estimated $40 sold.

Clear Street first reported a position in NKGNW in Q2 2022 and held it in 7 quarters. The position peaked at $194 in Q3 2023. 30 funds tracked by Wall St. Rank hold NKGNW as of Q1 2024.

Clear Street reported no remaining NKGen Biotech, Inc. Warrants position as of Q1 2024 after selling out during the quarter.
Clear Street sold 491 NKGen Biotech, Inc. Warrants shares in Q1 2024, an estimated $40.
Clear Street first reported a position in NKGen Biotech, Inc. Warrants in Q2 2022 and held it in 7 quarters.
Clear Street's NKGen Biotech, Inc. Warrants position peaked at $194 in Q3 2023.
30 funds tracked by Wall St. Rank held NKGen Biotech, Inc. Warrants as of Q1 2024.

Based on Clear Street's 13F filing for Q1 2024, filed 13 May 2024.